{
    "N/R/U": null,
    "Applicant": "Parke-Davis, a Division of Pfizer Inc.",
    "BLA Number": "50294",
    "Proprietary Name": "Elase-chloromycetin",
    "Proper Name": "fibrinolysin and desoxyribonuclease combined [bovine], with chloramphenicol",
    "BLA Type": "351(a)",
    "Strength": "10MG/GM; 666UNITS/GM; 1UNIT/GM",
    "Dosage Form": "Ointment",
    "Route of Administration": "Topical",
    "Product Presentation": "Tube",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "1-Apr-64",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2205",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}